|
WO2021081448A1
|
|
Synergistic inhibitors of creb-mediated gene transcription
|
|
WO2021067874A1
|
|
Production of anti-viral monoclonal antibodies by hydrodynamic-based transfection
|
|
WO2021050565A1
|
|
Crispr-mediated capture of nucleic acids
|
|
US2021052155A1
|
|
Identifying retinal layer boundaries
|
|
WO2021034964A1
|
|
Modulation of t cell responses by ul18 of human cytomegalovirus
|
|
US2021045672A1
|
|
Systems and methods for capillary oximetry using optical coherence tomography
|
|
US2021033243A1
|
|
Multi-workstation computer display support structure for reducing ehr-related medical errors occurring during inter-professional patient rounds
|
|
WO2021016594A1
|
|
Second generation inhibitors of mitochondrial permeability transition pore with improved plasma stability
|
|
WO2021011496A1
|
|
Immunotherapeutic constructs and methods of their use
|
|
WO2021011501A1
|
|
Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor
|
|
WO2020247858A1
|
|
Hepatitis b virus-specific t cell responses
|
|
WO2020247859A2
|
|
Tumor-associated antigen-specific t cell responses
|
|
US2020369616A1
|
|
Alkoxycarbonate ester prodrugs for use as antimalarial agents
|
|
WO2020231839A1
|
|
Engineered bone marrow model
|
|
WO2020219949A1
|
|
Promoter sequence and related products and uses thereof
|
|
WO2020219968A1
|
|
Detecting avascular and signal reduction areas in retinas using neural networks
|
|
US2020342595A1
|
|
Detecting avascular areas using neural networks
|
|
US2020315649A1
|
|
Endarterectomy device
|
|
US2020288971A1
|
|
Visual field simulation using optical coherence tomography and optical coherence tomographic angiography
|
|
US2020273218A1
|
|
Automated detection of shadow artifacts in optical coherence tomography angiography
|
